These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29599181)

  • 21. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
    Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
    Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
    Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
    Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
    Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: H. pylori eradication therapy after subtotal gastrectomy for gastric cancer - can the qualitative be quantified?
    Genta RM
    Aliment Pharmacol Ther; 2013 Oct; 38(8):989-90. PubMed ID: 24074309
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori.
    Shinozaki S; Nomoto H; Kondo Y; Sakamoto H; Hayashi Y; Yamamoto H; Lefor AK; Osawa H
    Kaohsiung J Med Sci; 2016 May; 32(5):255-60. PubMed ID: 27316584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
    Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
    Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Kanayama S
    Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
    Kodama M; Murakami K; Okimoto T; Fujioka T
    Nihon Rinsho; 2008 Apr; 66(4):804-10. PubMed ID: 18409534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The search for optimal Helicobacter pylori eradication regimen: a mid 1997 update.
    Deltenre M; De Bruyne L; Ntounda R; De Koster E; Lamy V
    Acta Gastroenterol Belg; 1998; 61(3):344-7. PubMed ID: 9795469
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.
    Yazbek PB; Trindade AB; Chin CM; Dos Santos JL
    Dig Dis Sci; 2015 Oct; 60(10):2901-12. PubMed ID: 25999247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
    Dickey W; Kenny BD; McConnell JB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates.
    Huh CW; Youn YH; Jung da H; Park JJ; Kim JH; Park H
    PLoS One; 2016; 11(9):e0162258. PubMed ID: 27588679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary: H. pylori eradication therapy after subtotal gastrectomy for gastric cancer - can the qualitative be quantified? Authors' reply.
    Cho SJ; Choi IJ
    Aliment Pharmacol Ther; 2013 Oct; 38(8):991. PubMed ID: 24074310
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemorrhagic gastric hyperplastic polyps associated with long-term use of proton pump inhibitor in a case without Helicobacter pylori infection.
    Kinoshita S; Nishizawa T; Mori H; Kikuchi M
    J Clin Pharm Ther; 2019 Jun; 44(3):493. PubMed ID: 30773665
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
    Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
    Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
    Arai J; Niikura R; Hayakawa Y; Aoki T; Yamada A; Kawai T; Fujishiro M
    Gut; 2022 May; 71(5):1043-1044. PubMed ID: 34344784
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
    Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():627-31. PubMed ID: 11979859
    [No Abstract]   [Full Text] [Related]  

  • 40. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.